Xencor, Inc. (XNCR)
11.48
+0.21
(+1.86%)
USD |
NASDAQ |
May 22, 10:01
Xencor Shareholders Equity (Quarterly) : 515.63M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.19B |
| Rigel Pharmaceuticals, Inc. | 399.90M |
| Ultragenyx Pharmaceutical, Inc. | -236.00M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 736.85M |
| Total Liabilities (Quarterly) | 221.21M |
| Debt to Equity Ratio | 0.3397 |
| Current Ratio | 6.573 |
| Net Debt Paydown Yield | 1.27% |